FDA Reports Sharp Increase in Sales of Antibiotics for Food Animals
Report measures sales of antibiotics that are medically important to humans
Public-health groups urged the Obama administration to take more aggressive steps to limit and track the use of antibiotics in cows, chickens and other food animals after the Food and Drug Administration Friday reported a sharp increase in antibiotic sales between 2009 and 2013.
In a report on antibiotics that are medically important to humans, the FDA said sales of antibiotics approved for use in food animals jumped 20% between 2009 and 2013. The annual report from the FDA said a total of 32.6 million pounds of antibiotics were sold domestically for an approved use in animals in 2013. Of those, more than 60% were considered to be medically important.
The practice of giving antibiotics to animals—to promote quicker growth or prevent disease—is drawing increased scrutiny because some strains of bacteria have grown resistant to antibiotics, robbing humans of a powerful tool to fight infections. Antibiotic-resistant bacteria are responsible for some two million illnesses annually in the U.S., and more than 23,000 deaths, according to the Centers for Disease Control and Prevention.
‘Giving antibiotics to animals routinely is like giving antibiotics to your kids before they head off to day care when what they really should be doing is washing their hands.’
“The federal government needs to do more,” said Avinash Kar, a senior attorney at the Natural Resources Defense Council and an expert on antibiotics policies. The practice of giving routine doses of antibiotics to animals is akin to “giving antibiotics to your kids before they head off to day care when what they really should be doing is washing their hands.”
Gail Hansen, a senior officer at the antibiotics resistance project at Pew Charitable Trusts, said the government should be collecting more detailed data on how, when and where antibiotics are given to animals.
“This sales data underscores the need for more detailed information in order to evaluate policies intended to combat antibiotic resistance,” Ms. Hansen said.
The North American Meat Institute, which represents meat and poultry companies, dismissed Friday’s sales figures since they don’t indicate how the drugs were used in the animals and for what purposes.
“It is hard to glean much information about what the report means as far as the key issue of antibiotic resistance is concerned,” said Betsy Booren, the group’s vice president of scientific affairs.
RELATED
- At a Glance: Antibiotics and the Meat Industry
- Hunger for Organic Foods Stretches Supply Chain
- As Antibiotic Use in Livestock Grows, Dangers to Humans Rise
- White House Issues Plan to Fight Drug-Resistant Bacteria
- Parmalot: White House Plan for Limiting Antibiotic Resistance is Criticized
- McDonald’s to Curb Antibiotics in Chicken
Separate from government efforts, food companies have started to offer antibiotic-free meat, responding to consumers’ concerns.McDonald’s Corp. announced in March, for example, that it would stop selling McNuggets and other chicken products in the U.S. made from birds raised with drugs that are important to human health.
The White House unveiled a sweeping plan in March to fight the spread of drug-resistant superbugs and to preserve the effectiveness of existing antibiotics. The plan, which includes better data collection, sets a 2020 target to reduce illnesses caused by some of the most lethal microbes by 50% to 60%.
The FDA is pursuing a separate plan to get drug companies to phase out antibiotics that have been designed as growth promoters in animals. All drug companies have voluntarily agreed to comply and have until December 2016 to make the necessary changes.
The FDA is also calling on farmers and ranchers to get veterinary approval to use drugs to treat or prevent diseases. The Natural Resources Defense Council and other groups are concerned that the FDA’s plan will do little to curb the use of antibiotics, given the ability of farmers and ranchers to continue using the drugs for disease prevention.
The figures released by the FDA on Friday don’t reflect any declines made as a result of the agency’s plan. Instead, they’ll serve as a baseline of sorts to determine whether the FDA’s new plan is yielding results.
A report issued in September by the President’s Council of Advisors on Science and Technology reiterated that bacteria are growing increasingly resilient in large part because drugs are given too frequently to humans. The report said the use of drugs in animals were also a matter of serious concern.